Morikawa K et al. |
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726002
|
Arain TM et al. |
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726034
|
Shafran SD et al. |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. |
1996 |
N. Engl. J. Med. |
pmid:8676931
|
Shimoyama T et al. |
Validity of various diagnostic tests to evaluate cure of Helicobacter pylori infection. |
1996 |
J. Gastroenterol. |
pmid:8680535
|
Berg-Candolfi M and Candolfi E |
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection. |
1996 |
Int. J. Parasitol. |
pmid:9024879
|
MacConnachie AM |
Clarithromycin (klaricid, Abbott). |
1996 |
Intensive Crit Care Nurs |
pmid:8696027
|
Meier A et al. |
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. |
1996 |
J. Infect. Dis. |
pmid:8699066
|
Griffith DE et al. |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease. |
1996 |
Clin. Infect. Dis. |
pmid:8953085
|
Sellal A et al. |
[Maintenance treatment of cerebral toxoplasmosis in AIDS: role of clarithromycin-minocycline combination]. |
1996 |
Presse Med |
pmid:8685115
|
Schouenborg P |
[Clarithromycin]. |
1996 |
Ugeskr. Laeg. |
pmid:8686028
|
Goddard AF et al. |
Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. |
1996 |
Gastroenterology |
pmid:8690200
|
Lambert JR |
Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy. |
1996 |
Gastroenterology |
pmid:8690219
|
Bates JH |
Mycobacterium avium disease: progress at last. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665029
|
Wallace RJ et al. |
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665032
|
Pellegrin I et al. |
Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages. |
1996 |
J. Antimicrob. Chemother. |
pmid:9182107
|
Apseloff G et al. |
Severe neutropenia caused by recommended prophylactic doses of rifabutin. |
1996 |
Lancet |
pmid:8782773
|
Gisbert JP et al. |
Response to article by Forné et al. |
1996 |
Am. J. Gastroenterol. |
pmid:8561132
|
Steinman MA and Steinman TI |
Clarithromycin-associated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis. |
1996 |
Am. J. Kidney Dis. |
pmid:8546130
|
Pankuch GA et al. |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878583
|
Matsuoka N et al. |
Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. |
1996 |
Clin. Exp. Immunol. |
pmid:9099936
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Wintermeyer SM et al. |
Dirithromycin: a new macrolide. |
1996 |
Ann Pharmacother |
pmid:8893122
|
van der Hulst RW et al. |
Therapeutic options after failed Helicobacter pylori eradication therapy. |
1996 |
Am. J. Gastroenterol. |
pmid:8931413
|
Alder JD et al. |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies. |
1996 |
Am. J. Gastroenterol. |
pmid:8931416
|
Vilmà nyi E et al. |
Clarithromycin pharmacokinetics after oral administration with or without fasting in crossbred beagles. |
1996 |
J Small Anim Pract |
pmid:8934426
|
Yago K et al. |
[Protein binding of clarithromycin in patients with chronic renal failure]. |
1996 |
Jpn J Antibiot |
pmid:8935121
|
Koguchi M et al. |
[Antimicrobial activities of clarithromycin against clinical isolates]. |
1996 |
Jpn J Antibiot |
pmid:8935125
|
Tomioka H et al. |
[Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones]. |
1996 |
Kekkaku |
pmid:8999135
|
Tsuyuguchi K |
[In vitro anti-MAC activities of new quinolones in focus (1)]. |
1996 |
Kekkaku |
pmid:8999136
|
Sakatani M |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (1) Continuous positive cases (failure of the initial chemotherapy)]. |
1996 |
Kekkaku |
pmid:8999139
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Aoyama T et al. |
Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. |
1996 |
J. Pediatr. |
pmid:8917247
|
Koeck JL et al. |
Disseminated Mycobacterium simiae infection in a patient with AIDS: clinical features and treatment. |
1996 |
Clin. Infect. Dis. |
pmid:8909856
|
Liviu L et al. |
Pancreatitis induced by clarithromycin. |
1996 |
Ann. Intern. Med. |
pmid:8849171
|
Dammann HG |
[Helicobacter pylori eradication: triple therapy versus dual therapy]. |
1996 |
Fortschr. Med. |
pmid:8852685
|
Cone LA et al. |
Mania due to clarithromycin therapy in a patient who was not infected with human immunodeficiency virus. |
1996 |
Clin. Infect. Dis. |
pmid:8853002
|
Yousfi MM et al. |
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8853767
|
Schimkat M et al. |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus. |
1996 |
Ger J Ophthalmol |
pmid:8854102
|
Chiba N |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. |
1996 |
Am. J. Gastroenterol. |
pmid:8855737
|
Engelhardt E et al. |
[Postoperative infection with Mycobacterium chelonae]. |
1996 |
Hautarzt |
pmid:9036143
|
Stone GG et al. |
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. |
1996 |
Helicobacter |
pmid:9432314
|
Cammarota G et al. |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971300
|
Dammann HG |
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with H. pylori gastritis. |
1996 |
Dig. Dis. Sci. |
pmid:8617126
|
Meyboom RH et al. |
[Possible potentiation of phenprocoumon by clarithromycin and roxithromycin]. |
1996 |
Ned Tijdschr Geneeskd |
pmid:8628425
|
Hunt RH |
Eradication of Helicobacter pylori infection. |
1996 |
Am. J. Med. |
pmid:8644782
|
Torriani FJ et al. |
Disseminated Mycobacterium avium complex: correlation between blood and tissue burden. |
1996 |
J. Infect. Dis. |
pmid:8603975
|
Vakil N and Fennerty MB |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. |
1996 |
Am. J. Gastroenterol. |
pmid:8607487
|
Labenz J |
[Current developments in Helicobacter pylori therapy]. |
1996 |
Leber Magen Darm |
pmid:8965606
|
Treiber G |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. |
1996 |
Am. J. Gastroenterol. |
pmid:8607488
|
Grau E et al. |
Interaction between clarithromycin and oral anticoagulants. |
1996 |
Ann Pharmacother |
pmid:8968465
|
Shaheen N and Grimm IS |
Fulminant hepatic failure associated with clarithromycin. |
1996 |
Am. J. Gastroenterol. |
pmid:8607519
|
Horowitz RS et al. |
Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction. |
1996 |
Arch. Intern. Med. |
pmid:8607732
|
Muñoz N et al. |
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data. |
1996 |
IARC Sci. Publ. |
pmid:8923024
|
Labenz J et al. |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?]. |
1996 |
Dtsch. Med. Wochenschr. |
pmid:8565802
|
Dhaenens L et al. |
In-vitro activities of clarithromycin and other antimicrobial agents against Helicobacter pylori isolated from children. |
1996 |
J. Antimicrob. Chemother. |
pmid:8877551
|
Tursi A et al. |
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. |
1996 |
J. Clin. Gastroenterol. |
pmid:8877648
|
Goh KL et al. |
Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy. |
1996 |
Eur J Gastroenterol Hepatol |
pmid:8804868
|
Thor P et al. |
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia. |
1996 |
J. Physiol. Pharmacol. |
pmid:8877902
|
Ji B et al. |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878595
|
Heifets L |
Susceptibility testing of Mycobacterium avium complex isolates. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843278
|
Alper CM et al. |
Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843299
|
Chen S et al. |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection]. |
1996 |
Zhonghua Nei Ke Za Zhi |
pmid:9592303
|
Rana KZ et al. |
Clarithromycin does not affect phosphorylation of zidovudine in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843311
|
Liu W et al. |
[Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection]. |
1996 |
Zhonghua Nei Ke Za Zhi |
pmid:9592304
|
Flamm RK et al. |
Kill kinetics of antimicrobial agents against Helicobacter pylori. |
1996 |
J. Antimicrob. Chemother. |
pmid:8937967
|
Bermudez LE et al. |
Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. |
1996 |
J. Infect. Dis. |
pmid:8940212
|
Nagashima R et al. |
Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. |
1996 |
Gastroenterology |
pmid:8942749
|
Erah PO et al. |
Ion-pair high-performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice. |
1996 |
J. Chromatogr. B, Biomed. Appl. |
pmid:8832427
|
|
Three new studies expand understanding of MAC therapy. |
1996 |
Am J Health Syst Pharm |
pmid:8899122
|
Vangala R and Cernek PK |
Hypersensitivity reaction to clarithromycin. |
1996 |
Ann Pharmacother |
pmid:8833572
|
Ji B et al. |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834886
|
Yamamoto T et al. |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834892
|
Ji B et al. |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice? |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834894
|
Dattwyler RJ et al. |
Clarithromycin in treatment of early Lyme disease: a pilot study. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834900
|
Versalovic J et al. |
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834903
|
Wallace RJ et al. |
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807061
|
Gillum JG et al. |
Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807068
|
Gross U and Pohl F |
Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. |
1996 |
Curr. Top. Microbiol. Immunol. |
pmid:8791704
|
Peterson WL et al. |
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791947
|
Delchier JC et al. |
Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791948
|
Riff DS et al. |
Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report. |
1996 |
Helicobacter |
pmid:9398874
|
Harford W et al. |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. |
1996 |
Helicobacter |
pmid:9398875
|
Schwartz H et al. |
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report. |
1996 |
Helicobacter |
pmid:9398876
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
Jaup BK |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin. |
1996 |
Helicobacter |
pmid:9398878
|
Moayyedi P et al. |
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. |
1996 |
Helicobacter |
pmid:9398880
|
Mégraud F and Malfertheiner P |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995. |
1996 |
Helicobacter |
pmid:9398889
|
O'Morain C et al. |
Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. |
1996 |
Helicobacter |
pmid:9398893
|
Lind T et al. |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. |
1996 |
Helicobacter |
pmid:9398894
|
van der Hulst RW et al. |
Treatment of Helicobacter pylori infection: a review of the world literature. |
1996 |
Helicobacter |
pmid:9398908
|
|
NIAID study rules out high-dose clarithromycin for AIDS-related MAC. |
1996 |
AIDS Patient Care STDS |
pmid:11361534
|
|
New data suggest antibiotic clarithromycin is effective in prolonging life of AIDS patients. |
1996 |
AIDS Patient Care STDS |
pmid:11361575
|
|
Clarithromycin and MAC. |
1996 |
AIDS Patient Care STDS |
pmid:11361673
|
Harris AW et al. |
Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971302
|
Moshkowitz M et al. |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971304
|
Laine L et al. |
Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971306
|
Patel KB et al. |
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891147
|
Barry AL et al. |
Reassessment of methods for testing the susceptibility of Haemophilus influenzae to clarithromycin. |
1996 |
J. Antimicrob. Chemother. |
pmid:8722555
|
|
H. pylori treatment recognized by FDA. |
1996 |
Am J Health Syst Pharm |
pmid:8725200
|